WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'8301 Infant (under 12 months) mortality rate: 332
GDP / capita (US$): 6'4501 Child (under 5 years) mortality rate: 412

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 10'848  10'671  10'496  10'324  10'157  8'495  6'794  5'369 
Births 276  275  273  271  270  267  250  213 
Surviving infants 266  264  262  260  258  251  229  187 
Pop. less than 5 years 1'294  1'279  1'264  1'258  1'261  1'218  1'063  869 
Pop. less than 15 years 3'743  3'720  3'695  3'674  3'661  3'382  2'786  2'288 
Female 15-49 years 2'764  2'712  2'660  2'608  2'554  2'056  1'635  1'263 

Number of reported case

(Click for retrospective incidence data for Bolivia (Plurinational State of))
Diphtheria 31 
Japanese encephalitis
Measles 122  820  4'181 
Mumps 586  764  1'096  1'781  680 
Pertussis 75  31  10  159  2'377 
Polio* 48 
Rubella 434 
Rubella (CRS)
Tetanus (neonatal) 46 
Tetanus (total)** 46  153 
Yellow fever 50  46 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bolivia (Plurinational State of))
Vaccine year result method % card seen                                                
BCG 2012  100  EPI     96  85  87  90  90  95  48  30 
DTP1 2006  97  DHS   77  94  86  85  90  87  98 
DTP3 2012  93  EPI     85  80  80  82  80  89  41  11 
DTP4          28 
IPV1         
HepB_BD         
HepB3 2012  93  EPI     85  81  80  82  80  89 
Hib3 2012  93  EPI     85  81  80  82  80  89 
JapEnc         
MCV1          86  83  84  84  79  99*  53  13 
MCV2         
PCV1          99* 
PCV3          56 
Pol3 2012  93  EPI     85  80  79  82  80  89  50  14 
Rota1          90  81  80  85  83 
Rota_last          85  77  76  80  76 
Rubella1          86  83  84  84  79 
TT2plus 2012  75  EPI     31  26  27  76 
PAB         
VAD1          57  50  47  49  48  19 
YFV 2012  86  EPI     73  80  82  81  63  12 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bolivia (Plurinational State of))
BCG 99  99  99  99  98  92  65  30 
DTP1 98  98  97  98  97  92  66  32 
DTP3 94  94  93  95  91  75  41  11 
HepB3 94  94  93  95  91  77 
HepB_BD
Hib3 94  94  93  95  91  77 
MCV1 95  95  96  96  88  84  53  13 
MCV2
PAB 87  76  76  74  74  67  23 
PCV3 56 
Pol3 95  95  93  95  90  74  50  14 
Rota_last 99  93  91  91  87 
YFV 91  91  93  92  74 

Number of districts in the country 339  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
94 
   
/
|
|
\
Greater or equal to 90% 25
From 80 to 89% 17
From 50 to 79% 45
Less than 50% 12
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6, 18 months; 4 years; Yes
HPV Yes From 2016
IPV 2 months; Yes From October 2015
Influenza_Adult >= 65 years; Yes and adults with chronic diseases, pregnant women, health care workers
Influenza_Pediatric 6-11, 12-23 months; Yes
MMR 12 months; Yes
MenBC 1st contact; +1 month; No outbreaks
OPV 2, 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +1, +6 months; +1, +1 year; Yes
YF 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2011-2015  2010-2015    2010-2015  2007-2011   
Nº of districts with microplans that include activities to raise immunization coverage number 339  105  105  105  105  105   

System performance

Total Nº districts in country number 339  337  337  337  337  327  327 
Nº districts with DTP3 coverage >=80% number 145  139  137  159  154  161  174 
% of districts with DTP3 coverage >=80% From 0 to 100% 43  41  41  47  46  49  53 
Nº districts with measles (MCV1) coverage >=95% number 86  86  106  95  79  100  91 
% of districts with MCV1 coverage >=95% From 0 to 100% 25  26  31  28  23  31  28 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 95  99  80  100    85  85 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.